ATE288498T1 - Methoden zur inhibierung von helicobacter pylori - Google Patents

Methoden zur inhibierung von helicobacter pylori

Info

Publication number
ATE288498T1
ATE288498T1 AT99931212T AT99931212T ATE288498T1 AT E288498 T1 ATE288498 T1 AT E288498T1 AT 99931212 T AT99931212 T AT 99931212T AT 99931212 T AT99931212 T AT 99931212T AT E288498 T1 ATE288498 T1 AT E288498T1
Authority
AT
Austria
Prior art keywords
methods
helicobacter pylori
inhibiting
inhibiting helicobacter
molecules
Prior art date
Application number
AT99931212T
Other languages
English (en)
Inventor
Reuse Hilde De
Stephane Skouloubris
Valerie Cussac
Agnes Labigne
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE288498T1 publication Critical patent/ATE288498T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/58—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving urea or urease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/121—Helicobacter (G); Campylobacter (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99931212T 1998-06-30 1999-06-29 Methoden zur inhibierung von helicobacter pylori ATE288498T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/107,383 US6190667B1 (en) 1998-06-30 1998-06-30 Methods of inhibiting Helicobacter pylori
PCT/EP1999/004490 WO2000000634A2 (en) 1998-06-30 1999-06-29 METHODS OF INHIBITING $i(HELICOBACTER PYLORI)

Publications (1)

Publication Number Publication Date
ATE288498T1 true ATE288498T1 (de) 2005-02-15

Family

ID=22316366

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99931212T ATE288498T1 (de) 1998-06-30 1999-06-29 Methoden zur inhibierung von helicobacter pylori

Country Status (9)

Country Link
US (5) US6190667B1 (de)
EP (1) EP1092040B1 (de)
JP (1) JP4445128B2 (de)
AT (1) ATE288498T1 (de)
AU (1) AU4779599A (de)
DE (1) DE69923559T2 (de)
ES (1) ES2237119T3 (de)
PT (1) PT1092040E (de)
WO (1) WO2000000634A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190667B1 (en) * 1998-06-30 2001-02-20 Institut Pasteur Methods of inhibiting Helicobacter pylori
US5942409A (en) * 1998-07-31 1999-08-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Process for identification of substances modulating ureI dependent mechanisms of Helicobacter pylori metabolism
AU2002307448A1 (en) * 2001-04-20 2002-11-05 President And Fellows Of Harvard College Methods and compositions for the modulation of biofilm formation
US20070092502A1 (en) * 2005-09-01 2007-04-26 Allergan, Inc. Method of Treating Glaucoma
CA2688900C (en) 2005-11-21 2012-01-03 Faroex Ltd. Assembled structure of a sandwich panel and a connecting member using adhesive attachment
CA2599560C (en) 2006-09-01 2011-04-12 Faroex Ltd. Structural shear plate for a vehicle
ES2545209T3 (es) 2008-04-22 2015-09-09 Corporación Alimentaria Peñasanta (Capsa) Método de obtención de una nueva cepa de Bifidobacterium bifidum con actividad frente a la infección por Helicobacter pylori
CN111471780A (zh) * 2020-03-16 2020-07-31 上海力拜生物科技有限公司 幽门螺杆菌唾液检测生物标志物及其应用
CN117050169B (zh) * 2023-08-14 2024-04-26 苏州东抗生物科技有限公司 一种针对UreA蛋白的单克隆抗体及其应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USH25H (en) 1985-06-17 1986-02-04 Tennessee Valley Authority Thiophosphoryl triamide as a urease inhibitor
FR2637612B1 (fr) 1988-10-06 1993-09-10 Pasteur Institut Sequences de nucleotides codant pour une proteine a activite ureasique
GB8928625D0 (en) 1989-12-19 1990-02-21 3I Res Expl Ltd H.pylori dna probes
JPH04364160A (ja) 1990-08-03 1992-12-16 Terumo Corp チオウレア誘導体およびこれを含有する抗菌剤および抗潰瘍剤
JPH0559038A (ja) 1991-09-06 1993-03-09 Terumo Corp チオウレア誘導体及びこれを含有する医薬製剤
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
US5409903A (en) 1992-02-18 1995-04-25 Urecap Corporation Method and compositions for the treatment of H. pylori and dermatitis
US5472695A (en) * 1992-06-25 1995-12-05 Technion Research And Development Foundation Ltd. Therapeutic application of a thyme extract and in - vitro methods for inhibiting the growth and urease activity of helicobacter pylori
MX9304638A (es) 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
US5972336A (en) * 1992-11-03 1999-10-26 Oravax Merieux Co. Urease-based vaccine against helicobacter infection
WO1995014093A1 (en) * 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
US5843460A (en) * 1993-05-19 1998-12-01 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
US5441875A (en) 1993-07-23 1995-08-15 Brigham And Women's Hospital Urea transporter polypeptide
US5560912A (en) * 1994-06-27 1996-10-01 Technion Research & Development Foundation Ltd. Method for inhibiting growth of helicobacter pylori
CA2219201A1 (en) 1995-04-28 1996-10-31 Oravax, Inc. Multimeric, recombinant urease vaccine
EP0745674B1 (de) 1995-06-02 2006-07-05 Eisai Co., Ltd. Helicobacter Polypeptide, deren Herstellung und Verwendung
SK165197A3 (en) 1995-06-07 1999-01-11 Astra Ab Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
US6087358A (en) * 1995-06-26 2000-07-11 Pathogenesis Corporation Nitro-[2,1-b]imidazopyran compounds and antibacterial uses thereof
FR2736360B1 (fr) * 1995-07-04 1997-09-05 Pasteur Institut Clonage et caracterisation du gene fiba de h.pylori, production de souches aflagellees
TW290498B (en) * 1995-07-19 1996-11-11 Andover Coated Products Inc Elastic bandage
SE506529C2 (sv) 1996-01-23 1997-12-22 Semper Ab Användning av ett laktoperoxidassystem för framställning av ett läkemedel mot Helicobacter pylori
US5900410A (en) 1996-08-27 1999-05-04 Hartmann; John F. Monotherapy of peptic ulcers and gastritis
EP0939800A2 (de) * 1996-10-17 1999-09-08 Institut Pasteur HELICOBACTER ANTIGEN (gamma-GLUTAMYLTRANSFERASE) UND SEQUENZEN DIE SIE KODIEREN
EP0973886B1 (de) * 1997-01-24 2005-03-23 AVI BioPharm, Inc. Verfahren und konjugat zur behandlung von helicobacter pylori-infektionen
US5876946A (en) * 1997-06-03 1999-03-02 Pharmacopeia, Inc. High-throughput assay
US5985631A (en) * 1997-09-12 1999-11-16 Oravax-Merieux Co. Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease
US6190667B1 (en) * 1998-06-30 2001-02-20 Institut Pasteur Methods of inhibiting Helicobacter pylori
US5942409A (en) * 1998-07-31 1999-08-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Process for identification of substances modulating ureI dependent mechanisms of Helicobacter pylori metabolism
CA2347135C (en) * 1998-10-02 2008-03-25 3M Innovative Properties Company Laminated elastic composites
US20040142343A1 (en) * 2002-08-16 2004-07-22 Yung-Fu Chang Helicobacter bizzozeronii urease genes and their uses in diagnostic and treatment methods

Also Published As

Publication number Publication date
WO2000000634A3 (en) 2000-04-13
JP4445128B2 (ja) 2010-04-07
ES2237119T3 (es) 2005-07-16
DE69923559T2 (de) 2006-02-16
US20050176077A1 (en) 2005-08-11
JP2002519039A (ja) 2002-07-02
WO2000000634A2 (en) 2000-01-06
US20020102269A1 (en) 2002-08-01
DE69923559D1 (de) 2005-03-10
US6190667B1 (en) 2001-02-20
PT1092040E (pt) 2005-06-30
EP1092040A2 (de) 2001-04-18
US6762051B2 (en) 2004-07-13
US7517666B2 (en) 2009-04-14
US20040115772A1 (en) 2004-06-17
US6416968B1 (en) 2002-07-09
EP1092040B1 (de) 2005-02-02
AU4779599A (en) 2000-01-17

Similar Documents

Publication Publication Date Title
DE69939864D1 (de) Ppar-gamma modulatoren
ATE444967T1 (de) Spezifische bindungsmittel von human angiopoietin-2
ATE279181T1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
DE59902314D1 (de) Oligomerisiertes Organopolysiloxan-Cokondensat, dessen Herstellung und dessen Verwendung zur Behandlung von Oberflächen
PT1052905E (pt) Processo anti-germinativo de tuberculos e bolbos utilizando o eugenol e/ou o isoeugenol
DE60034871D1 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
EA200200001A1 (ru) Способ повышения содержания флавоноидов и фенольных компонентов в растениях
DE69927688D1 (de) Antivirales Mittel in Kombination mit Strahlentherapie zur Verwendung in der Behandlung von Krebs
ATE288498T1 (de) Methoden zur inhibierung von helicobacter pylori
ATE345354T1 (de) Methode zur identifizierung von helicobacter antigenen
MXPA05009743A (es) Composiciones con actividad hematopoyetica e inmune.
ATE338142T1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
WO2002062205A3 (en) Methods for diagnosing and treating heart disease
ATE261724T1 (de) Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
DE60137459D1 (de) Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen
WO2003028536A3 (en) Methods for diagnosing and treating heart disease
BR9915442A (pt) Método para a cobertura de um produto de alimento com colágeno
DE69936779D1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
GB0016362D0 (en) Tetraspanin modulation
NZ514691A (en) Method to type prion proteins
DE69930419D1 (de) Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie
WO2003028537A3 (en) Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
WO2003023048A3 (en) METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l)
WO2003007800A3 (en) Methods for diagnosing and treating diseases and conditions of the digestive system and cancer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1092040

Country of ref document: EP

REN Ceased due to non-payment of the annual fee